These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 26755877)
1. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? Park YS; Lee CH; Kim JW; Shin S; Park CM World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Dietrich CF Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
9. Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers. Kim YY; Park MS; Aljoqiman KS; Choi JY; Kim MJ Clin Mol Hepatol; 2019 Sep; 25(3):223-233. PubMed ID: 30661336 [TBL] [Abstract][Full Text] [Related]
10. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905 [TBL] [Abstract][Full Text] [Related]
11. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050 [TBL] [Abstract][Full Text] [Related]
13. Benign focal liver lesions masquerading as primary liver cancers on MRI. Subramanian M; Low HM; Kim MJ; Tan CH Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432 [TBL] [Abstract][Full Text] [Related]
14. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944 [TBL] [Abstract][Full Text] [Related]
15. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma. Sagrini E; Iavarone M; Stefanini F; Tovoli F; Vavassori S; Maggioni M; Renzulli M; Salvatore V; Stefanescu H; Colombo M; Bolondi L; Piscaglia F United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118 [TBL] [Abstract][Full Text] [Related]
16. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669 [TBL] [Abstract][Full Text] [Related]
17. Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging. Sheybani A; Gaba RC; Lokken RP; Berggruen SM; Mar WA Curr Gastroenterol Rep; 2017 Oct; 19(11):58. PubMed ID: 29044439 [TBL] [Abstract][Full Text] [Related]
18. Hepatic hemangiomas: the various imaging avatars and its mimickers. Mathew RP; Sam M; Raubenheimer M; Patel V; Low G Radiol Med; 2020 Sep; 125(9):801-815. PubMed ID: 32249391 [TBL] [Abstract][Full Text] [Related]
19. Appearance of Focal Liver Lesions Using Contrast-Enhanced Magnetic Resonance Imaging Using Gadofosveset Trisodium, an Intravascular (Blood-Pool) Contrast Agent: A Pictorial Essay. Cheung HM; Law C; Shoichet M; Karanicolas PJ; Coburn N; Milot L Can Assoc Radiol J; 2016 Aug; 67(3):242-9. PubMed ID: 27318891 [No Abstract] [Full Text] [Related]
20. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Kim JH; Joo I; Lee JM Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]